BioWorld-International-2010-12-22
EpiTherapeutics, Abbott in Epigenetics Oncology Deal
EpiTherapeutics, Abbott in Epigenetics Oncology Deal
EpiTherapeutics ApS, which is developing cancer drugs based on epigenetics targets, entered its first drug discovery pact, with Abbott, of Abbott Park, Ill. (BioWorld International)

